PARSIPPANY, N.J., March 06, 2025 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (NASDAQ:PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies, today announced the granting of inducement awards on March 4, 2025 to six new employees under Pacira’s Amended and Restated 2014 Inducement Plan (the “Inducement Plan”) as a material inducement to each employee’s entry into employment with the company. In accordance with Nasdaq Listing Rule 5635(c)(4), the awards were approved by the Compensation Committee of the Board of Directors (the “Committee”) without stockholder approval.
Five employees received stock options to purchase an aggregate of 23,500 shares of Pacira common stock and six employees received restricted stock units for an aggregate of 29,400 …
